glp 1 compounded semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with injectable products GLP-1 Drugs from the Gray

Can heat in Florida ruin Ozempic, Wegovy, or Mounjaro

Women should pay particular attention to monitoring IGF-1 levels and should avoid both compounds during pregnancy or while breastfeeding

Where GLP-1 agonists such as semaglutide activate only one receptor, Retatrutide simultaneously engages three receptors each playing a distinct role in energy metabolism

What GLP-1 medications might change (and why it matters for pills) GLP1 receptor agonists affect the gut in ways that are central to how they work: they can slow gastric emptying and often cause nausea, sometimes vomiting, and sometimes diarrhea

People with type 2 diabetes have a higher risk of developing long COVID and pulmonary fibrosis, a condition where scar tissue builds up in the lungs and makes breathing more difficult

FDA-approved for treating obesity, as well as other conditions, including sleep apnea, the medications are increasingly being used off-label by people who dont qualify based on factors like their BMI (which has long been a controversial measure of health, FWIW)